Transplantation and Artificial Pancreas
Transplantation and the artificial pancreas are two advanced approaches in the treatment of diabetes, especially for those with severe or uncontrolled type 1 diabetes.
-
Transplantation: This involves the transplant of a pancreas or insulin-producing islet cells from a donor to a person with diabetes. Pancreatic transplants are often considered for people with type 1 diabetes who experience severe complications, such as kidney failure. The goal is to restore normal insulin production and glucose control. However, it requires lifelong immunosuppressive medications to prevent rejection, which carry risks such as infections and other complications.
-
Artificial Pancreas: This is a technological innovation designed to automate blood glucose control. It combines continuous glucose monitoring (CGM) and insulin pumps to mimic the function of a healthy pancreas. The system adjusts insulin delivery based on real-time glucose levels, providing more stable glucose control with less manual input. The artificial pancreas has shown promise in improving quality of life, reducing hypoglycemic episodes, and making diabetes management more convenient. However, challenges like device reliability, cost, and the need for continuous monitoring of device performance remain.
Both options aim to improve diabetes management and reduce complications, but they require careful consideration of individual needs, risks, and the latest technological advances.